Barth RF - Search Results

1

Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.

Wu G, Barth RF, Yang W, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA. Wu G, et al. Among authors: barth rf. Bioconjug Chem. 2004 Jan-Feb;15(1):185-94. doi: 10.1021/bc0341674. Bioconjug Chem. 2004. PMID: 14733599

2

Boron neutron capture therapy: principles and potential.

Gahbauer R, Gupta N, Blue T, Goodman J, Barth R, Grecula J, Soloway AH, Sauerwein W, Wambersie A. Gahbauer R, et al. Recent Results Cancer Res. 1998;150:183-209. doi: 10.1007/978-3-642-78774-4_12. Recent Results Cancer Res. 1998. PMID: 9670292 Review.

3

The Chemistry of Neutron Capture Therapy.

Soloway AH, Tjarks W, Barnum BA, Rong FG, Barth RF, Codogni IM, Wilson JG. Soloway AH, et al. Among authors: barth rf. Chem Rev. 1998 Jun 18;98(4):1515-1562. doi: 10.1021/cr941195u. Chem Rev. 1998. PMID: 11848941 No abstract available.

4

The Chemistry of Neutron Capture Therapy. (Chem. Rev. 1998, 98, 1515. Published on the Web May 20, 1998).

Soloway AH, Tjarks W, Barnum BA, Rong FG, Barth RF, Codogni IM, Wilson JG. Soloway AH, et al. Among authors: barth rf. Chem Rev. 1998 Sep 24;98(6):2389-2390. doi: 10.1021/cr980493e. Chem Rev. 1998. PMID: 11848966 No abstract available.

5

Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.

Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML, Nawrocky MM, Coderre JA, Rofstad EK. Barth RF, et al. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):858-68. doi: 10.1016/s0360-3016(01)02734-1. Int J Radiat Oncol Biol Phys. 2002. PMID: 11849812

6

Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy.

Pan XQ, Wang H, Shukla S, Sekido M, Adams DM, Tjarks W, Barth RF, Lee RJ. Pan XQ, et al. Among authors: barth rf. Bioconjug Chem. 2002 May-Jun;13(3):435-42. doi: 10.1021/bc015557y. Bioconjug Chem. 2002. PMID: 12009931

7

Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.

Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA. Barth RF, et al. Cancer Res. 2002 Jun 1;62(11):3159-66. Cancer Res. 2002. PMID: 12036929

8

Electrospray ionization mass spectrometry coupled to reversed-phase ion-pair high-performance liquid chromatography for quantitation of sodium borocaptate and application to pharmacokinetic analysis.

Gibson CR, Staubus AE, Barth RF, Yang W, Kleinholz NM, Jones RB, Green-Church KB, Tjarks W, Soloway AH. Gibson CR, et al. Among authors: barth rf. Anal Chem. 2002 May 15;74(10):2394-9. doi: 10.1021/ac0112723. Anal Chem. 2002. PMID: 12038766

9

Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.

Sudimack JJ, Adams D, Rotaru J, Shukla S, Yan J, Sekido M, Barth RF, Tjarks W, Lee RJ. Sudimack JJ, et al. Among authors: barth rf. Pharm Res. 2002 Oct;19(10):1502-8. doi: 10.1023/a:1020408716807. Pharm Res. 2002. PMID: 12425468

10

Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.

Yang W, Barth RF, Adams DM, Ciesielski MJ, Fenstermaker RA, Shukla S, Tjarks W, Caligiuri MA. Yang W, et al. Among authors: barth rf. Cancer Res. 2002 Nov 15;62(22):6552-8. Cancer Res. 2002. PMID: 12438250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters